ITEM 5.07 Submission of Matters to a Vote of Security Holders

Urologix, Inc. (the "Company") held its 2012 Annual Meeting of Shareholders (the "Annual Meeting") on November 16, 2012 at the Sheraton Minneapolis West, 12201 Ridgedale Drive, Minnetonka, Minnesota, beginning at 4:00 p.m., local time. Of the 20,782,868 shares of the Company's common stock outstanding and entitled to vote at the Annual Meeting, 19,219,365 shares were present either in person or by proxy. The final results of voting for each matter submitted to a vote of shareholders at the Annual Meeting are set forth below.

Proposal 1. To elect two (2) directors of the Company to hold office for a term of three years or until their respective successors have been elected and shall qualify.

Nominee For Withhold Broker Non-Vote Mitchell Dann 10,938,903 69,530 8,210,932 Stryker Warren, Jr. 10,948,103 60,330 8,210,932

Proposal 2. To approve the Urologix, Inc. 2012 Stock Incentive Plan.

For Against Abstain Broker Non-Vote 10,164,710 822,952 20,771 8,210,932

Proposal 3. To ratify and approve the appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending June 30, 2013.

For Against Abstain Broker Non-Vote 18,842,212 375,603 1,550 -0-

As a result, Mitchell Dann and Stryker Warren, Jr. were each elected as a director of the Company, the Urologix, Inc. 2012 Stock Incentive Plan was approved, and the appointment of KPMG LLP was ratified and approved.